Value of cytologic Papanicolaou smears and polymerase chain reaction screening for human papillomavirus DNA in detecting anal intraepithelial neoplasia: Comparison with histology of a surgical sample

Cancer

Volumn 118, Issue 24, 2012, Pages 6031-6038

  Etienney, Isabelle ^a   Vuong, Sarra ^b   Si Mohamed, Ali ^c   Fléjou, Jean François ^d   Atienza, Patrick ^a   Bauer, Pierre ^a  

^a Diaconesses Croix Saint Simon Teaching Hospital   (France)

^b Anatomy Pathology Center   (France)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^d HÔPITAL SAINT ANTOINE   (France)

Author keywords

anal intraepithelial neoplasia; anal Papanicolaou smear; DNA; high risk HPV; polymerase chain reaction detection of human papillomavirus (HPV); screening test

Indexed keywords

VIRUS DNA;

ADULT; AGED; ANUS CARCINOMA; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DNA DETERMINATION; FEMALE; GENETIC SCREENING; GENOTYPE; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INFECTION RISK; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SEXUAL BEHAVIOR; VIRUS DETECTION; WART VIRUS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANUS NEOPLASMS; CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; CYTODIAGNOSIS; DNA, VIRAL; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; NEOPLASM GRADING; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PROGNOSIS; SENSITIVITY AND SPECIFICITY; TUMOR VIRUS INFECTIONS; YOUNG ADULT;

EID: 84870697205     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.27671     Document Type: Article

References (32)

1. Halford JA, Batty T, Boost T, et al. Comparison of the sensitivity of conventional cytology and the ThinPrep imaging system for 1083 biopsy confirmed high-grade squamous lesions. Diagn Cytopathol. 2010; 38: 318-326.
2. Goldstone SE, Enyinna CS, Davis TW,. Detection of oncogenic human papillomavirus and other predictors of anal high-grade dysplasia in men who have sex with men with abnormal cytology. Dis Colon Rectum. 2009; 52: 31-39.
3. Palefsky JM,. Anal cancer prevention in HIV-positive men and women. Curr Opin Oncol. 2009; 21: 433-438.
4. Mathews C, Caperna J, Cachay ER, Cosman B,. Early impact and performance characteristics of an established anal dysplasia screening program: program evaluation considerations. Open AIDS J. 2007; 1: 11-20.
5. Calore EE, Nadal SR, Manzione CR, Horta SC, Santos RR, Nadal LM,. Anal cytology in patients with AIDS. Diagn Cytopathol. 2010; 38: 260-263.
6. Vadjic CM, Anderson JS, Hillman RJ, Medley G, Grulich AE,. Blind sampling is superior to anoscope guided sampling for screening for anal intraepithelial neoplasia. Sex Transm Infect. 2005; 81: 415-418.
7. Nathan M, Singh N, Garrett N, Hickey N, Prevost T, Sheaff M,. Performance of anal cytology in a clinical setting when measured against histology and high resolution anoscopy findings. AIDS. 2010; 24: 373-379.
8. Pineda CE, Berry JM, Jay N, Palefsky JM, Welton ML,. High-resolution anoscopy targeted surgical destruction of anal high-grade squamous intraepithelial lesions: a ten-year experience. Dis Colon Rectum. 2008; 51: 829-835; discussion 835-837.
9. Etienney I, Vuong S, Daniel F, et al. Prevalence of anal cytologic abnormalities in a French referral population: a prospective study with special emphasis on HIV, HPV, and smoking. Dis Colon Rectum. 2008; 51: 67-72.
10. Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA. 2002; 287: 2140-2141.
11. Resnick RM, Cornelissen MT, Wright DK, et al. Detection and typing of human papillomavirus in archival cervical cancer specimens by DNA amplification with consensus primers. J Natl Cancer Inst. 1990; 82: 1477-1484.
12. Munoz N, Bosch FX, de Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003; 348: 518-527.
13. Bean S, Meara R, Vollmer RT, et al. P16 improves interobserver agreement in diagnosis of anal intraepithelial neoplasia. J Low Genit Tract Dis. 2009; 13: 145-153.
14. Bean S, Chhieng DC, Roberson J, et al. Anal-rectal cytology: correlation with human papillomavirus status and biopsy diagnoses in a population of HIV-positive patients. J Low Genital Tract Dis. 2010; 14: 90-96.
15. Park IU, Palefsky JM,. Evaluation and management of anal intraepithelial neoplasia in HIV-negative and HIV-positive men who have sex with men. Curr Infect Dis Rep. 2010; 12: 126-133.
16. Berry JM, Palefsky JM, Jay N, et al. Performance characteristics of anal cytology and human papillomavirus testing in patients with high resolution anoscopy guided biopsy of high grade anal intraepithelial neoplasia. Dis Colon Rectum. 2009; 52: 239-247.
17. Fox PA, Seet JE, Stebbing J, et al. The value of anal cytology and human papillomavirus typing in the detection of anal intraepithelial neoplasia: a review of cases from an anoscopy clinic. Sex Transm Infect. 2005; 81: 142-146.
18. Chiao EY, Giordano TP, Palefsky JM, Tyring S, El Serag H,. Screening HIV-infected individuals for anal cancer precursor lesions: a systematic review. Clin Infect Dis. 2006; 43: 223-233.
19. Friedlander MA, Stier E, Lin O,. Anorectal cytology as a screening tool for anal squamous lesions. cytologic, anoscopic and histologic correlation. Cancer. 2004; 102: 19-26.
20. Nahas CS, da Silva Filho EV, Segurado AA, et al. Screening anal dysplasia in HIV-infected patients: is there an agreement between anal Pap smear and high resolution anoscopy guided biopsy? Dis Colon Rectum. 2009; 52: 1854-1860.
21. Berry JM, Palefsky JM,. Invited commentary. Dis Colon Rectum. 2009; 52: 1860-1863 [Comment on Dis Colon Rectum. 2009;52:1854-1860].
22. Indinnimeo M, d'Ettorre G, Fiore A, et al. Diagnosis of anal papillomavirus infection: polymerase chain reaction or cytology? Int J Infect Dis. 2011; 15: e232-e235.
23. Bean S,. Anal-rectal cytology: a review. Diagn Cytopathol. 2009; 38: 538-546.
24. Bulkmans NW, Berkhof J, Rozendaal L, et al. Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5 year follow-up of a randomised controlled implementation trial. Lancet. 2007; 370: 1764-1772.
25. Naucler P, Ryd W, Tornberg S, et al. Human papillomavirus and Papanicolaou tests to screen to cervical cancer. N Engl J Med. 2007; 357: 1589-1597.
26. Wong AK, Chan RC, Aggarwal N, et al. Human papillomavirus genotypes in anal intraepithelial neoplasia and anal carcinoma as detected in tissue biopsies. Mod Pathol. 2010; 23: 144-150.
27. De Vuyst H, Clifford GM, Nascimento MC, Madeleine MM, Franceschi S,. Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis. Int J Cancer. 2009; 124: 1626-1636.
28. Darragh TM, Winkler B,. Anal cancer and cervical cancer screening: key differences. Cancer Cytopathol. 2011; 119: 5-19.
29. Heraclio SdeA, Souza AS, Pinto FR, Amorim MM, Oliveira Mde L, Souza PR,. Agreement between methods for diagnosing HPV-induced anal lesions in women with cervical neoplasia. Acta Cytol. 2011; 55: 218-224.
30. Goldstone SE,. High resolution anoscopy is a crucial component of anal dysplasia screening. Dis Colon Rectum. 2010; 53: 364-365.
31. Lemarchand N, Tanne F, Aubert M, et al. Is routine pathologic evaluation of hemorrhoidectomy specimens necessary? Gastroenterol Clin Biol. 2004; 28: 659-661.
32. Bauer P, De Parades V, Etienney I, Daniel F, Atienza P,. About "Is routine pathologic evaluation of hemorrhoidectomy specimens necessary?" [Article in French.] Gastroenterol Clin Biol. 2005; 29: 213-214.